Dollars for Profs
Dig Into University Researchers' Outside Income and Conflicts of Interest
Published Dec. 6, 2019
This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.
Conflict of Interest
Institutions must file significant disclosures to the National Institutes of Health if they determine financial relationships could affect the design, conduct or reporting of the NIH-funded research. The NIH provided us with their entire financial conflict of interest database, with filings from 2012 through 2019.
Should you be removed from our database? Contact us at [email protected]. Read more below.
Timothy Garvey
George Washington University, Department: Biostatistics & Other Math Sci
Should you be removed from our database? Contact us at [email protected]. Read more below.
Vivus, Inc
Equity Interest - Publicly traded entity (e.g., stock, stock option, or other ownership interest)
The outcome of the research is of significant business interest to the entity and therefore the financial interest could likely change based on the research results. In addition, the investigator with the conflict is a Member Advisory Board and Speaker.
Glycemia Reduction Approaches in Diabetes: A comparative effectiveness study
T2DM, a chronic disease with long-term complications, affects 25 million persons in the US. Clinical trials have established the importance of lowering glucose levels to delay or prevent complications of diabetes that cause more vision loss, kidney failure and amputations than any other disease. Still, the medications most likely to maintain goal glucose levels over time are unknown thus the GRADE study will identify the most effective means of treating T2DM, comparing drug effects on glucose levels, adverse effects, diabetes complications, and quality of life, and will have major public health implications.
Filed on January 26, 2014.
Tell us what you know about Timothy Garvey's disclosure
We're still reporting about conflicts of interest. Is there something you'd like to tell us about this disclosure?
Other search results for: “Timothy Garvey”
Name | Institution | Type | Company | Disclosed Value |
---|---|---|---|---|
Timothy Garvey | George Washington University | Conflict of Interest | CME Incite | $20,000 - $39,999 |
Timothy Garvey | George Washington University | Conflict of Interest | Global Directions in Medicine | $0 - $4,999 |
Timothy Garvey | George Washington University | Conflict of Interest | PRI-Med | $5,000 - $9,999 |
Timothy Garvey | George Washington University | Conflict of Interest | Medikinetics | $10,000 - $19,999 |
Timothy Garvey | George Washington University | Conflict of Interest | BGB New York | $0 - $4,999 |
Timothy Garvey | George Washington University | Conflict of Interest | Lockwood Group | $0 - $4,999 |
Timothy Garvey | George Washington University | Conflict of Interest | American Association of Clinic | $0 - $4,999 |
Timothy Garvey | George Washington University | Conflict of Interest | American Association of Clinic | $5,000 - $9,999 |
Timothy Garvey | George Washington University | Conflict of Interest | Merck & Company | $5,000 - $9,999 |
Timothy Garvey | George Washington University | Conflict of Interest | Vivus, Inc | $0 - $4,999 |
Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.
Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.
ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.